mhra
MHRA records closure of an IDAP UCNA entry
The MHRA's 19 November 2026 IDAP guidance update records the closure of IDAP/DEU/009/2024/0001, without explaining the reason or practical consequences.

What Changed
The Medicines and Healthcare products Regulatory Agency (MHRA) updated its Innovative Devices Access Pathway (IDAP) guidance on 19 November 2026. The publication history states that the Unmet Clinical Need Authorisation (UCNA) attachment was amended to reflect the closure of IDAP/DEU/009/2024/0001.
The announcement does not identify the device concerned, explain the reason for closure or describe consequences for users. The entry alone should therefore not be interpreted as a safety alert or recall.
Who Is Affected
The development is relevant to IDAP participants, innovative medical-device developers and organisations monitoring access to these technologies within the National Health Service (NHS). The closure notice does not establish which products or organisations are directly affected.
IDAP aims to accelerate development of devices addressing unmet NHS clinical needs and support their integration into the UK market. The pilot was designed to provide eight selected applicants with partner support at key stages of product development.
Regulatory and Technical Implications
The pilot tests the main elements of an integrated regulatory and access pathway, generating learning to inform future IDAP development. The MHRA page labels the pilot-phase, application-guidance, and patient and public involvement documents as closed.
Closure of an individual UCNA entry is distinct from those document labels. The announcement does not establish a new restriction on placing a device on the market, continued use or the status of other authorisations.
Manufacturer Actions
Manufacturers potentially concerned can check the identifier in the current UCNA attachment against their own authorisation documentation. Any effect on supply or clinical use should be verified rather than inferred from the brief publication-history entry.
The announcement specifies no new application obligation, technical-documentation requirement or compliance deadline for manufacturers.
Confirmed Dates
The IDAP guidance was first published on 19 September 2023. The closure update is dated 19 November 2026; this is not separately identified as the effective date of closure.
A separate entry dated 30 April 2026 records a further extension for HistoSonics Inc's EDISON SYSTEM AND ACCESSORIES, listing 30 October 2026. The publication history does not explicitly connect that product with the closed identifier.
Official Source
The MHRA's GOV.UK publication, “The Innovative Devices Access Pathway (IDAP),” provides the publication history and a link to the UCNA attachment: https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap
Source and related services
Guidance: The Innovative Devices Access Pathway (IDAP) ↗Source date: 19/11/2026
This news provides general information and does not replace device-specific legal or conformity assessment advice.